A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Children

StatusFinished
Effective start/end date8/03/1031/03/11

Funding

  • MedImmune, LLC: $107,631.00

Keywords

  • Biotechnology & Drug Development, Immunology